908 Devices (MASS) to Release Quarterly Earnings on Tuesday

908 Devices (NASDAQ:MASS) will likely be posting its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 13th. Analysts expect 908 Devices to post earnings of ($0.29) per share and revenue of $11.90 million for the quarter.

908 Devices Stock Down 2.8 %

MASS stock opened at $5.63 on Friday. The firm has a market capitalization of $201.22 million, a PE ratio of -3.18 and a beta of 0.26. 908 Devices has a twelve month low of $1.81 and a twelve month high of $7.48. The stock’s 50 day moving average is $4.44 and its 200-day moving average is $3.22.

Wall Street Analyst Weigh In

MASS has been the topic of several recent analyst reports. Stephens restated an “overweight” rating and set a $6.00 price objective on shares of 908 Devices in a research note on Wednesday, January 15th. Weiss Ratings restated a “sell (d-)” rating on shares of 908 Devices in a report on Thursday, April 24th. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $5.33.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.